Iressa Shows Promise For Treatment Of Metastatic Breast Cancer When Combined With Hormonal Therapy

May 19th, 2008 | Category: Breast Cancer

Gefitinib, the once-promising drug previously approved as a second line treatment for lung cancer, plus known as Iressa, enhanced the effectiveness of hormonal therapy for the treatment of specific types of metastatic breast cancer,

according to a Phase II clinical trial led by researchers at The University of Texas M. D. Anderson Cancer Center.

Original post by Women’s Health / Gynecology News From Medical News Today

Share and Enjoy: These icons link to social bookmarking sites where readers can share and discover new web pages.
  • Digg
  • del.icio.us
  • Netvouz
  • DZone
  • ThisNext
  • MisterWong
  • Wists
  • BlinkList
  • Furl
  • IndianPad
  • Netscape
  • Reddit
  • Simpy
  • Spurl
  • StumbleUpon
  • Technorati
Related Articles
  • Solvent-Free Abraxane(R) Combined With Targeted Therapy Bevacizumab Evaluated As First-Line Treatment For Metastatic Breast Cancer
  • Risk Of Lobular Breast Cancer Increased Fourfold After Just 3 Years Of Combined HRT
  • Survival Of Women With Metastatic Breast Cancer Not Improved By Group Therapy
  • New Drug Combination Is Able To Eradicate Breast Metastases In Mice
  • BC Cancer Agency Study Shows New Drugs Improve Survival For Metastatic Breast Cancer

    • No comments yet. Be the first.

    Leave a reply

    You must be logged in to post a comment.